Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Boston Scientific (BSX)

Boston Scientific Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:BSX
DateTimeSourceHeadlineSymbolCompany
24/04/202412:31IH Market NewsU.S. Futures Display Mixed Results Amid Earnings, WTI and Brent Crude Prices Dip in June Futures TradingNYSE:BSXBoston Scientific Corporation
24/04/202411:30PR Newswire (US)Boston Scientific Announces Results for First Quarter 2024NYSE:BSXBoston Scientific Corporation
08/04/202405:00PR Newswire (US)Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software ModuleNYSE:BSXBoston Scientific Corporation
01/04/202413:00PR Newswire (US)Boston Scientific Announces Conference Call Discussing First Quarter 2024 ResultsNYSE:BSXBoston Scientific Corporation
01/03/202411:55PR Newswire (US)Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated BalloonNYSE:BSXBoston Scientific Corporation
27/02/202421:15PR Newswire (US)Boston Scientific Announces Completion of €2.0 Billion Offering of Senior NotesNYSE:BSXBoston Scientific Corporation
23/02/202402:27PR Newswire (US)Boston Scientific Announces Pricing of €2.0 Billion of Senior NotesNYSE:BSXBoston Scientific Corporation
05/02/202413:00PR Newswire (US)Boston Scientific to Participate in TD Cowen's 44th Annual Health Care ConferenceNYSE:BSXBoston Scientific Corporation
31/01/202411:30PR Newswire (US)Boston Scientific Announces Results for Fourth Quarter and Full Year 2023NYSE:BSXBoston Scientific Corporation
31/01/202411:29IH Market NewsU.S. Futures Waver Ahead of Fed Decision Amid Mixed Corporate Earnings; Oil Prices SlideNYSE:BSXBoston Scientific Corporation
31/01/202411:25PR Newswire (US)Boston Scientific Receives FDA Approval for FARAPULSE™ Pulsed Field Ablation SystemNYSE:BSXBoston Scientific Corporation
08/01/202421:55PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.NYSE:BSXBoston Scientific Corporation
08/01/202416:36Dow Jones NewsAxonics Shares Climb 20% After Acquisition by Boston ScientificNYSE:BSXBoston Scientific Corporation
08/01/202412:41Dow Jones NewsBoston Scientific To Acquire Axonics For About $3.7 BillionNYSE:BSXBoston Scientific Corporation
08/01/202412:00PR Newswire (US)Boston Scientific Announces Agreement to Acquire Axonics, Inc.NYSE:BSXBoston Scientific Corporation
08/01/202412:00Business WireAxonics Announces Definitive Agreement to be Acquired by Boston ScientificNYSE:BSXBoston Scientific Corporation
05/01/202413:00PR Newswire (US)Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 ResultsNYSE:BSXBoston Scientific Corporation
28/12/202321:00PR Newswire (US)Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial FibrillationNYSE:BSXBoston Scientific Corporation
17/11/202314:00PR Newswire (US)Boston Scientific Closes Acquisition of Relievant Medsystems, Inc.NYSE:BSXBoston Scientific Corporation
01/11/202312:00PR Newswire (US)Boston Scientific to Participate in Stifel's 2023 Healthcare ConferenceNYSE:BSXBoston Scientific Corporation
26/10/202311:30PR Newswire (US)BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR THIRD QUARTER 2023NYSE:BSXBoston Scientific Corporation
25/10/202322:18AllPennyStocks.comMicrocap Offers Unique Opportunity for Investors In $10 Billion SCI IndustryNYSE:BSXBoston Scientific Corporation
25/10/202320:32Dow Jones NewsBoston Scientific Gets Positive Results for Heart-Failure DeviceNYSE:BSXBoston Scientific Corporation
25/10/202319:29PR Newswire (US)Boston Scientific AGENT™ Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE TrialNYSE:BSXBoston Scientific Corporation
24/10/202320:18PR Newswire (US)REAL-PE Study Demonstrates Statistically Significant Lower Major Bleeding Rates with the EKOS™ Endovascular System Compared to Mechanical Thrombectomy Device for Treatment of Pulmonary EmbolismNYSE:BSXBoston Scientific Corporation
11/10/202316:19Dow Jones NewsBoston Scientific Down Over 6%, on Pace for Largest Percent Decrease Since May 2022 -- Data TalkNYSE:BSXBoston Scientific Corporation
02/10/202311:30PR Newswire (US)Boston Scientific Announces Conference Call Discussing Third Quarter 2023 ResultsNYSE:BSXBoston Scientific Corporation
21/09/202311:45PR Newswire (US)CVS Health appoints Michael F. Mahoney to its Board of DirectorsNYSE:BSXBoston Scientific Corporation
19/09/202312:45Dow Jones NewsBoston Scientific to Buy Relievant Medsystems for Initial $800 MillionNYSE:BSXBoston Scientific Corporation
19/09/202312:00PR Newswire (US)Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.NYSE:BSXBoston Scientific Corporation
 Showing the most relevant articles for your search:NYSE:BSX